SEARCH PUBMED selected publications  Munsie LN, Caron N, Desmond CR, Truant R. Lifeact cannot visualize some forms of stress-induced twisted F-actin. Nat Methods. 2009 May;6(5):317. Truant R, Atwal RS, Desmond C, Munsie L, Tran T. Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases. FEBS J. 2008 Sep;275(17):4252-62. Epub 2008 Jul 15. Review. Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R.  Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet. 2007 Nov 1;16(21):2600-15. Truant R, Atwal R, Burtnik A. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease Prog Neurobiol. 2007 Jan 19. Truant R, Raymond LA, Xia J, Pinchev D, Burtnik A, Atwal RS. Canadian Association of Neurosciences Review: polyglutamine expansion neurodegenerative diseases. Can J Neurol Sci. 2006 Aug;33(3):278-91. Taylor J, Grote SK, Xia J, Vandelft M, Graczyk J, Ellerby LM, Laspada AR, Truant R. Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal. J Biol Chem. 2005 Nov 28;  Irwin S, Vandelft M, Pinchev D, Howell JL, Graczyk J, Orr HT, Truant R. 2005. RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci. 2005 Jan 1;118(Pt 1):233-42. Ray Truant. 2003. Nucleocytoplasmic Transport of Huntingtin and Huntington's Disease. Clin. Neurosci. Res., 3(3):157-164. Xia J, Lee DH, Taylor J, Vandelft M, Truant R. 2003. Huntingtin contains a highly conserved nuclear export signal. Hum Mol Genet. 2003 Jun 15;12(12):1393-403. Howell, J.L. and Ray Truant. 2002. A Nucleocytoplasmic Protein Shuttle assay Using Laser Confocal Microscopy and FRAP. Biotechniques. 32(1) p.80-87.